logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & policies
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Support
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For gastroenterology
    • For pathology
    • For our customers
    • Request a presentation
  • About us
    • Customer cases
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
    • Information & Policies
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Support
    • Investor relations & media
  • SV
  • |
  • EN

Inify Laboratories announces application periods for fully guaranteed private placement and fully guaranteed repair issue

Investor News 2025-12-09
STOCKHOLM – 9 December 2025 – Reference is made to the stock exchange announcement made by Inify Laboratories AB (the “Company”) on 12 November 2025, regarding a proposed fully guaranteed […]
Read More

Bulletin from the extraordinary general meeting of Inify Laboratories AB

Annual General Meeting, Investor News 2025-12-04
Today, December 4, 2025, an extraordinary general meeting was held in INIFY Laboratories AB, reg. no. 559345-4431 (the "Company"). At the meeting, 66,655,976 shares were represented, corresponding to 84.5 per […]
Read More

Inify Laboratories: Board announces updated timetable for settlement in proposed Private Placement and Repair Issue

Investor News 2025-12-03
STOCKHOLM – December 3, 2025 – The board of directors of Inify Laboratories AB ("Inify" or the "Company") announces its intention to postpone the last date of payment in the […]
Read More

Inify Laboratories – notice of Extraordinary General Meeting on December 4, 2025

Annual General Meeting, Investor News 2025-11-12
Stockholm – November 12, 2025 – Inify Laboratories AB (publ), a unique laboratory service that provides cancer diagnostics within pathology, hereby invites its shareholders to Extraordinary General Meeting on December […]
Read More

Inify Laboratories: Notice of Extraordinary General Meeting and proposed fully guaranteed equity issue with proceeds of NOK 100 million

Annual General Meeting, Investor News 2025-11-12
STOCKHOLM – November 12, 2025 – Inify Laboratories AB ("Inify" or the "Company") will in a separate press release call for an extraordinary general meeting (the "EGM") to be held […]
Read More

Correction – Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Financial reports, Investor News 2025-10-29
In connection with the publication of the company's Q3 2025 Financial Report, it was discovered that the amount for personnel costs in the parent company's income statement was incorrect. The […]
Read More

Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical operations on track for launch early 2026

Investor News 2025-10-29
STOCKHOLM – October 29, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, expanded its service offering during the third quarter with the addition of […]
Read More

Inify Laboratories – mandatory notification of trade

Investor News, Primary Insider Transactions 2025-08-29
Stockholm, Sweden, August 29, 2025; Inify Laboratories AB (publ.) has been notified that the following transactions have been completed by a primary insider in Inify; Martin Ingvar, board member and […]
Read More

Inify Laboratories: Solid growth in Sweden and first patient diagnostics delivered in the UK

Financial reports, Investor News 2025-08-27
STOCKHOLM – August 27, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver solid sales growth of 54% in the second quarter, […]
Read More

Inify Laboratories deliver diagnostics for its first patient case in the UK in collaboration with Parkside Frimley

Investor News 2025-06-26
STOCKHOLM – June 26, 2025 – Inify Laboratories, an ultra-modern laboratory service that provides cancer diagnostics within pathology, is proud to announce a significant milestone with the successful processing of […]
Read More
  • 1
  • 2
  • 3
  • …
  • 8

  • Our services

    Inify laboratory services

    For urology

    For gastroenterology

    For pathology

    For our customers

    Request a presentation

    Customer cases

    Information & policies

  • Inify Laboratories

    News

    Events

    Newsletter

    Publications & presentations

    Career

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Support

    Find Inify Laboratories

  • Social media

    LinkedIn

    YouTube

    X

© Inify® Laboratories